Authors: Lohr, M Hoffmeyer, A Kroger, JC Freund, M Hain, J Holle, A Karle, P Knofel, WT Liebe, S Muller, P Nizze, H Renner, M Saller, RM Wagner, T Hauenstein, K Gunzburg, WH Salmons, B

Citation: M. Lohr et al., Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma, LANCET, 357(9268), 2001, pp. 1591-1592

Authors: Muller, P Ostwald, C Puschel, K Brinkmann, B Plath, F Kroger, J Barten, M Nizze, H Schareck, WD Hauenstein, K Liebe, S Lohr, JM

Citation: P. Muller et al., Low frequency of p53 and ras mutations in bile of patients with hepato-biliary disease: a prospective study in more than 100 patients, EUR J CL IN, 31(3), 2001, pp. 240-247

Authors: Lohr, M Bago, ZT Bergmeister, H Ceijna, M Freund, R Gelbmann, W Gunzburg, WH Jesnowski, R Hain, J Hauenstein, K Henninger, W Hoffmeyer, A Karle, P Kroger, JC Kundt, G Liebe, S Losert, U Muller, P Probst, A Puschel, K Renner, M Renz, R Saller, R Salmons, B Schuh, M Schwendenwein, I von Rombs, K Wagner, T Walter, I

Citation: M. Lohr et al., Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study, J MOL MED-J, 77(4), 1999, pp. 393-398